Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Bladder Cancer treatment details. Chemotherapy. Korea University College of Medicine, Seoul, Korea

Survival: 11.3 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Methotrexate
Country: Korea
City/State/Province: Seoul
Hospital: Korea University College of Medicine
Journal: Link
Date: 4/2014

This study involved 28 metastatic urothelial carcinoma patients who were previously treated with gemcitabine and cisplatin. The median patient age was 64 years and 75% were male.

Patients were treated with the chemotherapy regimen called MVAC, which consists of methotrexate, vinblastine, doxorubicin, and cisplatin.

The most severe toxicities were grade 4 neutropenia and anemia. Grade 1-2 anorexia and nausea were also reported.

The median overall survival was 11.3 months.

Correspondence: Dr. Kyong Hwa Park; email:

E-mail to a Friend Email Physician More Information